Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Endocrine Connections|December 12, 2018
Metastatic neuroendocrine neoplasia treatments in patients over 70 years of ageAlberto Bongiovanni, Federica Recine, Flavia Foca, et al.
Disease Markers|January 11, 2019
Grading of Neuroendocrine Carcinomas: Correlation of 68Ga-PET/CT Scan with Tissue BiomarkersChiara Liverani, Alberto Bongiovanni, Laura Mercatali, et al.
Cardiovascular Research|July 15, 2015
A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndromeCristina Moreno, Anna Oliveras, Alicia de la Cruz, et al.
Frontiers in Oncology|June 8, 2023
Circulating hsa-miR-5096 predictsMartine Bocchini, Marcella Tazzari, Sara Ravaioli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2015
Peptide receptor radionuclide therapy with (177)Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and (18)F-FDG PETAnnarita Ianniello, Maddalena Sansovini, Stefano Severi, et al.
Molecules (Basel, Switzerland)|February 14, 2019
Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST ProtocolAnna Sarnelli, Maria Luisa Belli, Valentina Di Iorio, et al.
Frontiers in Oncology|April 23, 2020
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-AnalysisAlberto Bongiovanni, Chiara Liverani, Federica Recine, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 31, 2020
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective studyGiovanni Paganelli, Maddalena Sansovini, Silvia Nicolini, et al.
Neuroendocrinology|November 21, 2024
Lu-PRRT Used More Intensively on Advanced Gastro-Entero-Pancreatic and Lung Neuroendocrine Neoplasms: Preliminary Results on Toxicity from a Randomized StudyIlaria Grassi, Silvia Nicolini, Irene Marini, et al.
Pageof 13